Chen, Y., Chang, S., Chang, C., Chang, C., Lai, Y., Wei, Y., & Chen, C. (2021). Real-world effectiveness of second-line Afatinib versus chemotherapy for the treatment of advanced lung squamous cell carcinoma in immunotherapy-naïve patients. BMC.
Style de citation Chicago (17e éd.)Chen, You-Yi, Shih-Chieh Chang, Cheng-Yu Chang, Chun-Fu Chang, Yi-Chun Lai, Yu-Feng Wei, et Chung-Yu Chen. Real-world Effectiveness of Second-line Afatinib Versus Chemotherapy for the Treatment of Advanced Lung Squamous Cell Carcinoma in Immunotherapy-naïve Patients. BMC, 2021.
Style de citation MLA (8e éd.)Chen, You-Yi, et al. Real-world Effectiveness of Second-line Afatinib Versus Chemotherapy for the Treatment of Advanced Lung Squamous Cell Carcinoma in Immunotherapy-naïve Patients. BMC, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.